Citation:Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, et al 2001

Citation

Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, et al. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. J Urol 2001 Oct;166(4):1339-42 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11547069.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, et al 2001	For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, does measurement of %free PSA when compared with total PSA measurement improve the detection of any prostate cancer or of high grade prostate cancer on biopsy?	Dr. med. univ. Dana Stefanovic	completed
Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, et al 2001 2	For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, does measurement of %free PSA when compared with total PSA measurement improve the detection of any prostate cancer or of high grade prostate cancer on biopsy?	Cindy Peng	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, does measurement of %free PSA when compared with total PSA measurement improve the detection of any prostate cancer or of high grade prostate cancer on biopsy?|]] (compare critical appraisals)
• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, does measurement of %free PSA when compared with total PSA measurement improve the detection of any prostate cancer or of high grade prostate cancer on biopsy?|]] (compare critical appraisals)

Cited by

1. Testing with variants of PSA to improve sensitivity after an initial total PSA ≤ 3.0 ng/mL